Australian professional tennis player Nick Kyrgios was provisionally suspended Wednesday after testing positive for cocaine [1, 2].
The suspension of one of the sport's most prominent and polarizing figures raises questions about athlete conduct and the rigor of anti-doping enforcement during major tournaments.
The provisional suspension follows a urine sample collected during the 2026 Wimbledon Championships [1, 2]. The sample returned a positive result for cocaine, which is a prohibited substance under the anti-doping rules established by the International Tennis Federation [1, 2].
Kyrgios addressed the situation in a statement. "I made a huge mistake and I take full responsibility for my actions," Kyrgios said [1].
Officials from the ATP and tournament organizers announced the suspension on Aug. 19 [1, 3]. The player will remain sidelined from professional competition while the governing bodies conduct a full investigation into the violation [3].
An ATP spokesperson confirmed that the organization is adhering to the standard disciplinary protocol. "We take any violation of the anti-doping code very seriously and will follow the established process," the spokesperson said [3].
The case marks a significant blow to the Australian's career trajectory following his participation in the summer's most prestigious grass-court event. While the current status is a provisional suspension [1, 2], the final penalty will depend on the outcome of the formal investigation [3].
“"I made a huge mistake and I take full responsibility for my actions."”
This suspension places Kyrgios in the crosshairs of the International Tennis Federation's strict anti-doping framework. Because the positive test occurred during a Grand Slam event, the investigation will likely focus on whether the substance was used for performance enhancement or as a recreational drug, though both typically trigger significant bans under the current code.
